Revolution Medicines Inc RVMD

NAS: RVMD | ISIN: US76155X1000 30/04/2025

40,38 USD (-0,71%)

(-0,71%) 30/04/2025

Toon enkel gratis nieuws

11 maart 2021 · Revolution Medicines Announces Six Presentations at the American Association for Cancer Research Annual Meeting 2021 · Persbericht

9 maart 2021 · Revolution Medicines to Participate in Upcoming Investor Conferences · Persbericht

2 maart 2021 · Revolution Medicines Reports Fourth Quarter and Year-End 2020 Financial Results and Update on Corporate Progress · Persbericht

8 februari 2021 · Revolution Medicines Announces Closing of Upsized Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares · Persbericht

4 februari 2021 · Revolution Medicines Announces Pricing of Upsized $260.9 Million Public Offering of Common Stock · Persbericht

1 februari 2021 · Revolution Medicines Announces Proposed Public Offering of Common Stock · Persbericht

5 januari 2021 · Revolution Medicines to Provide R&D Pipeline Update, Including Progress of RAS(ON) Inhibitor Programs, During Presentation at 39th Annual J.P. Morgan Healthcare Conference · Persbericht

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe